9月12日 - ** 药物开发商 Cocrystal Pharma COCP.O 股价上涨 80% 至 2.59 美元
** 公司在一次会议上表示，其主要口服药物CDI-988显示出很强的抗病毒活性和良好的安全性，在小肠中的暴露率很高
** CDI-988 正在开发中，用于治疗和预防诺如病毒感染，诺如病毒感染会引起胃痛、呕吐和腹泻
** 截至上一交易日收盘，股价累计下跌 28.7
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.